HCA Healthcare (NYSE:HCA) Issues Quarterly Earnings Results

HCA Healthcare (NYSE:HCA) announced its earnings results on Friday. The company reported $6.96 earnings per share for the quarter, beating the consensus estimate of $5.64 by $1.32, Zacks reports. HCA Healthcare had a negative return on equity of 7,363.11% and a net margin of 8.21%.The firm had revenue of $19.16 billion for the quarter, compared to the consensus estimate of $18.55 billion. During the same quarter in the previous year, the business earned $4.90 EPS. The firm’s revenue for the quarter was up 9.6% on a year-over-year basis. HCA Healthcare updated its FY 2025 guidance to 27.000-28.000 EPS.

HCA Healthcare Price Performance

Shares of NYSE:HCA opened at $446.58 on Friday. HCA Healthcare has a fifty-two week low of $289.98 and a fifty-two week high of $461.56. The business has a 50-day moving average of $414.84 and a two-hundred day moving average of $382.03. The stock has a market capitalization of $104.50 billion, a P/E ratio of 17.26, a P/E/G ratio of 1.41 and a beta of 1.40.

HCA Healthcare Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Monday, December 29th. Shareholders of record on Monday, December 15th will be paid a $0.72 dividend. The ex-dividend date is Monday, December 15th. This represents a $2.88 dividend on an annualized basis and a yield of 0.6%. HCA Healthcare’s payout ratio is 12.11%.

Analysts Set New Price Targets

A number of research firms have recently commented on HCA. Wells Fargo & Company boosted their price objective on HCA Healthcare from $375.00 to $412.00 and gave the stock an “equal weight” rating in a research note on Tuesday, October 7th. The Goldman Sachs Group started coverage on HCA Healthcare in a report on Tuesday, October 14th. They issued a “buy” rating and a $470.00 target price on the stock. Wolfe Research cut HCA Healthcare from an “outperform” rating to a “peer perform” rating in a report on Monday, July 28th. JPMorgan Chase & Co. lifted their target price on HCA Healthcare from $360.00 to $370.00 and gave the stock a “neutral” rating in a report on Monday, August 4th. Finally, Weiss Ratings reiterated a “buy (b-)” rating on shares of HCA Healthcare in a report on Saturday. One analyst has rated the stock with a Strong Buy rating, eleven have given a Buy rating and nine have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $437.19.

Insider Buying and Selling at HCA Healthcare

In other HCA Healthcare news, EVP Michael S. Cuffe sold 3,836 shares of the business’s stock in a transaction dated Monday, September 8th. The stock was sold at an average price of $418.84, for a total value of $1,606,670.24. Following the completion of the sale, the executive vice president owned 31,503 shares of the company’s stock, valued at $13,194,716.52. The trade was a 10.85% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. 1.30% of the stock is owned by corporate insiders.

Hedge Funds Weigh In On HCA Healthcare

Several large investors have recently made changes to their positions in HCA. Brighton Jones LLC acquired a new position in shares of HCA Healthcare during the 4th quarter worth about $1,021,000. NewEdge Advisors LLC lifted its position in shares of HCA Healthcare by 11.9% during the 1st quarter. NewEdge Advisors LLC now owns 3,859 shares of the company’s stock worth $1,334,000 after purchasing an additional 409 shares during the last quarter. Sivia Capital Partners LLC lifted its position in shares of HCA Healthcare by 5.5% during the 2nd quarter. Sivia Capital Partners LLC now owns 630 shares of the company’s stock worth $241,000 after purchasing an additional 33 shares during the last quarter. Jump Financial LLC bought a new position in HCA Healthcare during the second quarter valued at about $2,073,000. Finally, Sei Investments Co. increased its stake in HCA Healthcare by 56.3% during the second quarter. Sei Investments Co. now owns 136,589 shares of the company’s stock valued at $52,328,000 after acquiring an additional 49,214 shares during the period. Institutional investors and hedge funds own 62.73% of the company’s stock.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.